Davern Capital Partners, LP

CIK 0002003147 · NY, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

Davern Capital Partners, LP reported 15 positions worth $586.5M as of June 30, 2026 (13F filed August 13, 2026). Largest holding: BNTX (12.0%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$586.5M
2026 Q2
Positions
15
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
86.8%
Est. Net Flow (Q)
2026 Q2
10 / 15 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1BNTXBIONTECH SESH$70.2M11.97%754,550
2ROIVROIVANT SCIENCES LTDSH$68.4M11.66%1,932,904
3RPRXROYALTY PHARMA PLCSH$64.8M11.05%1,155,809
4IONSIONIS PHARMACEUTICALS INCSH$63.3M10.80%798,709
5INSMINSMED INCSH$59.7M10.18%559,824
6REGNREGENERON PHARMACEUTICALSSH$57.8M9.85%92,640
7LEGNLEGEND BIOTECH CORPSH$34.4M5.87%1,191,522
8ALNYALNYLAM PHARMACEUTICALS INCSH$34.0M5.80%113,085
9NTRANATERA INCSH$32.3M5.51%118,975
10GPCRSTRUCTURE THERAPEUTICS INCSH$23.9M4.08%446,059

The free plan shows the top 10 positions. The remaining 5 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Davern Capital Partners, LP hold as of Q2 2026?

Davern Capital Partners, LP reported 15 positions worth $586.5M in its Q2 2026 13F filing. Largest positions: BNTX (12.0%), ROIV (11.7%), RPRX (11.0%), IONS (10.8%) and INSM (10.2%).

What did Davern Capital Partners, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Davern Capital Partners, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.